Bipolar Disorder Statistics for Pregnant Women

Bipolar disorder (BD) is a chronic and complex mental illness characterized by extreme shifts in mood, energy, and activity levels. While it affects approximately 2.8% of U.S. adults in any given year and 4.4% over a lifetime^[11], the perinatal period—the time during pregnancy and the year after birth—represents a period of heightened vulnerability. Hormonal fluctuations, psychosocial stressors, and pre-existing vulnerabilities can trigger or worsen mood episodes, making effective management critical for the health of both mother and child^[5]. Understanding the unique statistics related to this population is the first step toward improving screening, access to care, and health outcomes.

The perinatal period is a time of significant risk for the onset or recurrence of mood episodes for women with bipolar disorder. Data shows that approximately 3% of all childbearing women are affected by the condition^[10]. This vulnerability is not limited to those with a prior diagnosis; a meta-analysis found a bipolar disorder prevalence of 2.6% among perinatal women with no prior psychiatric history^[5]. The statistics below illustrate the scale of this issue and the high frequency of mood episodes during this sensitive time.

Despite the high risks, many pregnant women with bipolar disorder do not receive the care they need. A complex web of barriers, including fears about medication affecting the fetus, limited access to specialized providers, and societal stigma, contributes to a significant treatment gap^[7]. Many women report feeling abandoned by a healthcare system that dismisses their emotional distress as normal hormonal fluctuations^[20]. This leads to medication discontinuation and untreated symptoms, jeopardizing both maternal and infant health.

A major obstacle to effective care is the frequent misdiagnosis of bipolar disorder, which is often mistaken for unipolar depression^[25]. This is particularly dangerous during the perinatal period, as standard depression screening tools may not capture symptoms of hypomania or mania. Prescribing antidepressant monotherapy—a common treatment for depression—can trigger manic episodes or rapid cycling in individuals with bipolar disorder, worsening their condition^[5]. The average time from symptom onset to adequate treatment can be as long as eight years, a delay that can have severe consequences^[26].

Bipolar disorder affects women from all backgrounds, but certain populations face unique challenges and disparities in care. The average age of onset for bipolar disorder is typically in the mid-twenties^[30]. However, significant disparities exist based on race and sexual orientation. Minority women are often underdiagnosed and undertreated, while LGBTQ+ individuals face higher prevalence rates and barriers like discrimination and a lack of culturally competent providers^[31]. These factors compound the difficulties of managing a serious mental illness during pregnancy.

When bipolar disorder is not effectively managed during pregnancy, the consequences can be severe for both the mother and the infant. Untreated maternal behavioral health issues are a primary driver of adverse outcomes, including increased maternal morbidity and mortality^[29]. Suicide and drug overdose are leading causes of postpartum death. Furthermore, discontinuing mood stabilizers can increase the risk of relapse by up to fourfold and is linked to poor obstetrical outcomes like postpartum hemorrhage and higher hospitalization rates^[18]. For the baby, risks include preterm birth and low birth weight^[36].

Fortunately, effective treatments are available to help manage bipolar disorder during pregnancy. The most successful approaches involve integrated care, where obstetricians and psychiatrists collaborate to balance maternal mental health with fetal safety^[5]. While pharmacotherapy remains a cornerstone of treatment, non-pharmacological interventions like Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and mindfulness-based practices have proven highly effective in improving emotion regulation and reducing symptoms. Collaborative decision-making between the patient, her family, and her healthcare team is essential to weigh the risks of untreated illness against the potential risks of medication^[11].

A particularly vulnerable subgroup is pregnant women who are also caregivers for family members with chronic mental illnesses, including bipolar disorder. These individuals face a dual burden of managing their own health during pregnancy while navigating the stress of caregiving. This chronic stress is linked to adverse pregnancy outcomes and can precipitate relapse in those with pre-existing bipolar disorder^[41]. Unfortunately, many are unaware of or unable to access support services for themselves.

Recent years have seen shifts in both the prevalence and management of bipolar disorder during pregnancy. The COVID-19 pandemic significantly disrupted mental healthcare, leading to higher relapse rates, with as many as 27% of individuals with BD experiencing a new mood episode^[11]. At the same time, there has been a notable increase in diagnoses and service utilization, possibly due to greater awareness. Another emerging factor is social media use, which has been positively correlated with an escalation of manic symptoms in pregnant women with bipolar disorder^[44].

The failure to adequately treat bipolar disorder and other mental health conditions during the perinatal period carries a staggering economic cost. These costs are not limited to direct medical expenses but also include long-term societal costs related to lost productivity and increased use of social services. Investing in integrated and accessible maternal mental healthcare is not only a clinical imperative but also a fiscally responsible strategy that yields long-term benefits for families and society as a whole.